MedTrace Logo

Speech Therapy Settings in Cerebral Palsy

NCT07784790 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2026-08-25

No results posted yet for this study

Summary

Cerebral palsy (CP) is a common neurodevelopmental disorder affecting motor functions, cognition, and communication skills in children. Speech and language delays are prevalent among children with CP, significantly impacting their social interactions and daily life activities. This study aims to compare the effectiveness of hospital-based professional speech and language therapy with home-based parent-guided interventions for language development in children aged 18-36 months with CP. Participants will be assessed at baseline and after 6 months using standardized tools measuring motor functions, manual abilities, communication skills, and functional independence. The study will provide valuable insights into optimizing therapeutic approaches for language and communication development in children with CP.

Conditions

  • Cerebral Palsy

Interventions

BEHAVIORAL

Hospital-based Speech and Language Therapy

Participants will attend individual speech and language therapy sessions conducted by a professional speech-language therapist in a hospital setting.

BEHAVIORAL

Home-based Speech and Language Therapy

Parents will administer a structured speech and language intervention at home following a therapy program provided and supervised remotely by a professional speech-language therapist.

Sponsors & Collaborators

  • Selcuk University

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Months
Max Age
36 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-15
Primary Completion
2028-01-01
Completion
2028-01-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07784790 on ClinicalTrials.gov